Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now
10:56am, Tuesday, 26'th May 2026
CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains.
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
01:46pm, Monday, 25'th May 2026
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
LeMaitre to Participate at Upcoming Investor Conferences in June
04:25pm, Wednesday, 20'th May 2026
BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June.
Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround
10:35am, Wednesday, 13'th May 2026
LeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising
LeMaitre to Present at the Bank of America Healthcare Conference
05:15pm, Thursday, 07'th May 2026
BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 1
3 Reasons Growth Investors Will Love LeMaitre (LMAT)
01:45pm, Thursday, 07'th May 2026
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
LeMaitre (LMAT) Upgraded to Buy: Here's Why
01:00pm, Thursday, 07'th May 2026
LeMaitre (LMAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript
12:51am, Wednesday, 06'th May 2026
LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript
LeMaitre Vascular (LMAT) Tops Q1 Earnings Estimates
07:10pm, Tuesday, 05'th May 2026
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.48 per share a year ago.
LeMaitre Q1 2026 Financial Results
04:05pm, Tuesday, 05'th May 2026
BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterl
Comerica Bank Lowers Holdings in LeMaitre Vascular, Inc. $LMAT
02:41pm, Wednesday, 29'th Apr 2026
Comerica Bank trimmed its position in LeMaitre Vascular, Inc. (NASDAQ: LMAT) by 6.7% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The
Q1 2026 In Review - March Dividend Income Report
01:34pm, Thursday, 16'th Apr 2026
After 3 months in 2026, I heard more noise than quality information. Therefore, I don't intend to make any modifications to my portfolio at this point. Dollarama reported a mixed quarter with revenue
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
04:54pm, Tuesday, 14'th Apr 2026
BURLINGTON, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
02:39pm, Tuesday, 07'th Apr 2026
BURLINGTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 25th Annual Needham Virtual Healthcare Conference on Thu
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of “Moderate Buy” from Brokerages
04:43am, Sunday, 29'th Mar 2026
Shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat repor
